Revvity Basic EPS 2010-2025 | RVTY

Revvity basic eps for the twelve months ending June 30, 2025 was $2.36, a 65.03% increase year-over-year.

  • Revvity annual basic eps for 2024 was $0.002B, a 60.25% decline from 2023.
  • Revvity annual basic eps for 2023 was $0.006B, a 23.28% increase from 2022.
  • Revvity annual basic eps for 2022 was $0.005B, a 44.46% decline from 2021.

Revvity Basic EPS 2010-2025 | RVTY

  • Revvity annual basic eps for 2024 was $0.002B, a 60.25% decline from 2023.
  • Revvity annual basic eps for 2023 was $0.006B, a 23.28% increase from 2022.
  • Revvity annual basic eps for 2022 was $0.005B, a 44.46% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$151B
CVS Health (CVS)$87B
Elevance Health (ELV)$69.7B
Cencora (COR)$56.8B
DiDi Global (DIDIY)$25.8B
Labcorp Holdings (LH)$22.5B
Natera (NTRA)$22.4B
BioMerieux (BMXMF)$17.2B
EUROFINS SCIENT (ERFSF)$15.6B
ICON (ICLR)$14.2B
CochLear (CHEOY)$13.4B
Medpace Holdings (MEDP)$12.9B
Solventum (SOLV)$12.4B
Viatris (VTRS)$12.4B
Caris Life Sciences,�Inc (CAI)$10.3B
Sonic Healthcare (SKHHY)$9.1B
Avantor (AVTR)$8.8B
HealthEquity (HQY)$7.8B
Charles River Laboratories (CRL)$7.7B
Bausch + Lomb (BLCO)$5.2B
Sotera Health (SHC)$4.5B
BrightSpring Health Services (BTSG)$4B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.6B
Alignment Healthcare (ALHC)$3B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.5B
Premier (PINC)$2.1B
Progyny (PGNY)$2B